Long-term Extension Study of Ligelizumab in Food Allergy
Clinical trial NCT05678959 · TERMINATED
Trial details
- NCT number
- NCT05678959
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-27
- Primary completion
- 2025-03-06
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.